Share on

Asia-Pacific Laparoscopy Devices Market Research Report - Segmented By Product Type, Therapeutic Application, End Users & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Trends, Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 619
Pages: 141
Formats: report pdf report excel report power bi report ppt

APAC Laparoscopy Devices Market Size (2022 to 2027)

The size of the Laparoscopy Device Market in the Asia-Pacific was worth USD 1.36 billion in 2022 and estimated to be growing at a CAGR of 8.23%, to reach USD 2.03 billion by 2027.

The rise in the number of obese people, the increase in the number of minimally invasive procedures, and the growth in disposable income are expected to promote the growth rate of the APAC laparoscopy devices market. Also, the surge in laparoscopic-based bariatric surgeries for weight loss and technological advancements in these devices are expected to propel the laparoscopy devices market growth.

On the other hand, using these devices in surgical procedures helps keep bleeding to a minimum and preserves blood clotting; it positively influences the market growth. Moreover, the rising investments and financing in the healthcare industry undoubtedly generate several profitable possibilities for major regional players in this market. In addition, the benefits of minimally invasive surgeries over traditional open procedures include a better and enlarged picture of the organs or body parts being operated on and improved precision thanks to video-assisted technology.

The patients require fewer painkillers after minimally invasive treatments because they cause less post-operative discomfort. Also, owing to the benefits such as the hospital stay is usually less, and patients do not need to return to the hospital frequently because there are minimal incisions or sutures.  Further, the market development is aided by an increase in bariatric operations performed to help people lose weight.

The laparoscopy devices market in the APAC region is expected to be restrained by a lack of competence in laparoscopic operations and the high costs connected with this equipment and procedures. In addition, the factors such as undesirable effects such as infection, risk of injuring internal structures, and increase in the usage of robotics-assisted surgeries also impede the laparoscopy devices market in APAC.

This research report on the APAC laboratory devices market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Internal Closure Devices
  • Hand Access Instruments
  • Robotic-Assisted Surgical System
  • Laparoscopes
  • Direct Energy Systems
  • Insufflation Devices

By Therapeutic Application: 

  • Colorectal Surgery
  • Gynecological Surgery
  • General Surgery
  • Bariatric Surgery
  • Urological Surgery

By End Users: 

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, the Asia Pacific to offer great opportunities to this market in the coming years. This regional market will grow at a much higher rate than the US and European markets. Due to an increase in the geriatric population in countries like India and China, the market is estimated to experience robust growth in the forecast period. The APAC Laparoscopy Devices Market is expected to account for a significant share due to improvements in healthcare facilities, accessible disposable income, and the fastest-growing economic regions such as China, Japan, and India. Moreover, India is anticipated to emerge as a lucrative market with the highest development potential during the forecast period.

The Chinese laparoscopy devices market is projected to witness a major share in the APAC market during the forecast period. According to an official assessment, more than half of adults in China, or more than 500 million individuals, are now overweight. It is due to the country's tremendous economic expansion over the last several decades, resulting in significant changes in lifestyle, food, and exercise habits.

The Japanese laparoscopy devices market is predicted to showcase a healthy CAGR from 2022 to 2027. In Japan 2018, according to the Ministry of Health, Labour, and Welfare of Japan, over 162 males per 1 lakh people died because of cardiac illnesses, it has been increased from the year were more than 135 men per 100,000 people. In 2018, after the malignant neoplasm heart illnesses, it was the second-largest cause of mortality in its male population. Therefore, the rising prevalence of chronic diseases is projected to boost the number of minimally invasive surgical operations; it will also fuel market growth in the upcoming years.

The Australian laparoscopy devices market is forecasted to be showcase a prominent CAGR during the forecast period. According to the Australia Bureau of Statistics, 47.3 percent of Australians had one or more chronic diseases in the past years, with a significant increase from 2007-08, when 42.2 percent of people had one or more chronic conditions, two- fifth. Furthermore, due to the benefits connected with minimally invasive procedures, the adoption rate has been growing, boosting the market's overall growth.


A few of the notable companies that dominate the APAC laparoscopy devices market in this report are Boston Scientific Corporation, Karl Storz, ConMed, Aesculap, Covidien, Olympus, and Intuitive Surgical Stryker, Medtronic, B. Braun Melsungen AG, Ethicon US LLC, and Smith & Nephew.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample